CoChat
Sign Up
Cited by 5Myeloproliferative Neoplasms: Diagnosis and TreatmentPlatelet Disorders and TreatmentsHematological disorders and diagnostics

The DOI matches its Crossref record; the references it cites are not checked yet.

The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group

Schwarz, J, Penka, M, Indrák, K, Pospís̆ilová, D, Pytlík, R, Dulíc̆ek, P, Doubek, M, Křen, L, Campr, V, on behalf of the Czech MPD Working Group·2008·Leukemia
DOI 10.1038/leu.2008.93
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1038/leu.2008.93

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists haven’t been fetched yet

References 8 · Cited by 5

Metadata

Authors
Schwarz, J., Penka, M., Indrák, K., Pospís̆ilová, D., Pytlík, R., Dulíc̆ek, P., Doubek, M., Křen, L., Campr, V, & on behalf of the Czech MPD Working Group
Affiliations
  • Institute of Haematology and Blood Transfusion (CZ)
  • Masaryk University (CZ)
  • Palacký University Olomouc (CZ)
  • Charles University (CZ)
Corresponding author
Schwarz, J
ORCID
Venue
Leukemia
Publisher
Springer Science and Business Media LLC
Published
2008-04-17
Volume
22
Issue
11
Pages
2118-2119
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
DOI
10.1038/leu.2008.93
OpenAlex
W2026000013
Cited by
5
References
8
Citations by year
2022: 1 · 2015: 1 · 2012: 1
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Leukemia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Hematology › Hematological disorders and diagnostics
Keywords
WHO 2008 classification, myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, primary myelofibrosis, JAK2 V617F mutation, JAK2 exon 12 mutation, diagnostic criteria, Czech Republic, Czechoslovakia
MeSH terms
Humans, Myeloproliferative Disorders, Philadelphia Chromosome, Point Mutation, Janus Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review